A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PONTILLO, Alessandra et al. Polymorphisms in TREX1 and susceptibility to HIV-1 infection. International Journal of Immunogenetics, v. (online), p. 3 , 2013Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1111/iji.12071/pdf. Acesso em: 01 nov. 2024.
APA
Pontillo, A., Girardelli, M., Catamo, E., Duarte, A. J., & Crovella, S. (2013). Polymorphisms in TREX1 and susceptibility to HIV-1 infection. International Journal of Immunogenetics, (online), 3 . doi:10.1111/iji.12071
NLM
Pontillo A, Girardelli M, Catamo E, Duarte AJ, Crovella S. Polymorphisms in TREX1 and susceptibility to HIV-1 infection [Internet]. International Journal of Immunogenetics. 2013 ; (online) 3 .[citado 2024 nov. 01 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/iji.12071/pdf
Vancouver
Pontillo A, Girardelli M, Catamo E, Duarte AJ, Crovella S. Polymorphisms in TREX1 and susceptibility to HIV-1 infection [Internet]. International Journal of Immunogenetics. 2013 ; (online) 3 .[citado 2024 nov. 01 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/iji.12071/pdf
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTAL, Flavia et al. Dual effect of advanced glycation end products in pancreatic islet apoptosis. Diabetes/metabolism research and reviews, v. 29, n. 4, p. 296-307, 2013Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/dmrr.2390/pdf. Acesso em: 01 nov. 2024.
APA
Costal, F., Oliveira, E., Raposo, A., Machado-Lima, A., Peixoto, E., Roma, L., et al. (2013). Dual effect of advanced glycation end products in pancreatic islet apoptosis. Diabetes/metabolism research and reviews, 29( 4), 296-307. doi:10.1002/dmrr.2390
NLM
Costal F, Oliveira E, Raposo A, Machado-Lima A, Peixoto E, Roma L, Santos L, Faria JBL, Carpinelli AR, Giannella-Neto D, Passarelli M, Correa-Giannella ML. Dual effect of advanced glycation end products in pancreatic islet apoptosis [Internet]. Diabetes/metabolism research and reviews. 2013 ; 29( 4): 296-307.[citado 2024 nov. 01 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/dmrr.2390/pdf
Vancouver
Costal F, Oliveira E, Raposo A, Machado-Lima A, Peixoto E, Roma L, Santos L, Faria JBL, Carpinelli AR, Giannella-Neto D, Passarelli M, Correa-Giannella ML. Dual effect of advanced glycation end products in pancreatic islet apoptosis [Internet]. Diabetes/metabolism research and reviews. 2013 ; 29( 4): 296-307.[citado 2024 nov. 01 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/dmrr.2390/pdf
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA-JUNIOR, Edgar Borges de et al. High-performance liquid chromatography under partially denaturing conditions (dHPLC) is a fast and cost effective method for screening molecular defects: four novel mutations found in x-linked chronic granulomatous disease. Scandinavian Journal of Immunology, v. 76, n. 2, p. 158-166, 2012Tradução . . Disponível em: https://doi.org/10.1111/j.1365-3083.2012.02714.x. Acesso em: 01 nov. 2024.
APA
Oliveira-Junior, E. B. de, Prando, C., López, J. A., Arango, J. C., Buzolin, M., Rehder, J., et al. (2012). High-performance liquid chromatography under partially denaturing conditions (dHPLC) is a fast and cost effective method for screening molecular defects: four novel mutations found in x-linked chronic granulomatous disease. Scandinavian Journal of Immunology, 76( 2), 158-166. doi:10.1111/j.1365-3083.2012.02714.x
NLM
Oliveira-Junior EB de, Prando C, López JA, Arango JC, Buzolin M, Rehder J, Pedroza LA, Frazão JB, Dantas VM, Roxo Junior P, Grumach AS, Costa-Carvalho BT, Bustamante J, Condino-Neto A. High-performance liquid chromatography under partially denaturing conditions (dHPLC) is a fast and cost effective method for screening molecular defects: four novel mutations found in x-linked chronic granulomatous disease [Internet]. Scandinavian Journal of Immunology. 2012 ; 76( 2): 158-166.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1111/j.1365-3083.2012.02714.x
Vancouver
Oliveira-Junior EB de, Prando C, López JA, Arango JC, Buzolin M, Rehder J, Pedroza LA, Frazão JB, Dantas VM, Roxo Junior P, Grumach AS, Costa-Carvalho BT, Bustamante J, Condino-Neto A. High-performance liquid chromatography under partially denaturing conditions (dHPLC) is a fast and cost effective method for screening molecular defects: four novel mutations found in x-linked chronic granulomatous disease [Internet]. Scandinavian Journal of Immunology. 2012 ; 76( 2): 158-166.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1111/j.1365-3083.2012.02714.x
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Adriana Morgan et al. Thalidomide treatment down-regulates SDF-1a and CXCR4 expression in multiple myeloma patients. Leukemia Research, v. 33, n. 7, p. 970-973, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2008.09.018. Acesso em: 01 nov. 2024.
APA
Oliveira, A. M., Maria, D. A., Metzger, M. A., Linardi, C., Giorgi, R. R., Moura, F., et al. (2009). Thalidomide treatment down-regulates SDF-1a and CXCR4 expression in multiple myeloma patients. Leukemia Research, 33( 7), 970-973. doi:10.1016/j.leukres.2008.09.018
NLM
Oliveira AM, Maria DA, Metzger MA, Linardi C, Giorgi RR, Moura F, Martinez GA, Bydlowski SP, Novak EM. Thalidomide treatment down-regulates SDF-1a and CXCR4 expression in multiple myeloma patients [Internet]. Leukemia Research. 2009 ; 33( 7): 970-973.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.leukres.2008.09.018
Vancouver
Oliveira AM, Maria DA, Metzger MA, Linardi C, Giorgi RR, Moura F, Martinez GA, Bydlowski SP, Novak EM. Thalidomide treatment down-regulates SDF-1a and CXCR4 expression in multiple myeloma patients [Internet]. Leukemia Research. 2009 ; 33( 7): 970-973.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.leukres.2008.09.018